Management of radioiodine ablation therapy in haemodialysis patients with thyroid cancer: a case series of two patients

Management of radioiodine ablation therapy in haemodialysis patients with thyroid cancer: a case series of two patients

Abstract Background Radioiodine (131I) therapy in treatment of thyroid cancer, has a biological clearance that is significantly reduced in end-stage kidney disease (ESKD), leading to increased radiation exposure and potential myelotoxicity. For ESKD patients on haemodialysis (HD), there is no standa...

Full description

Saved in:
Bibliographic Details
Main Authors: Raymond Lin, Alessandra L. Malaroda, William J. Ryder, Veronica C. K. Wong, Nikki L. Wong
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Nephrology
Subjects:
Haemodialysis
Radioiodine therapy
Thyroid cancer
Nuclear medicine
Case series
Online Access:https://doi.org/10.1186/s12882-025-04348-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12882-025-04348-0

Similar Items